Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) made waves Monday afternoon not only with the announcement of its groundbreaking BioHive-2 supercomputer but also with a notable surge in its stock performance. read more.....»»

Shares of Inovio Pharmaceuticals Inc. gained 8.0% in premarket trading on Monday after the company said its experimental COVID-19 vaccine was safe and also triggered antibody titers in 400 or so adult participants in a P.....»»

Shares of Reviva Pharmaceuticals Holdings Inc. soared 76.6% in trading on Monday after the company said its experimental treatment .....»»

Shares of BioMarin Pharmaceuticals Inc. tumbled 6.6% in trading on Monday, the day after the company shared positive findings from a.....»»

GW Pharmaceuticals PLC shares rose 2.6% in the extended session Monday after the U.K.-based company sold much more of its cannabis derived epilepsy d.....»»

Alexion Pharmaceuticals (NASDAQ: ALXN) shares are trading higher on Monday. The company announced plans to initiate Phase 3 study of ULTOMIRIS in hospitalized patients with severe COVID-19. read more.....»»

Shares of Alexion Pharmaceuticals Inc. gained 2.1% in trading on Monday morning after the drugmaker announced it plans to conduct a Phase 3 trial testing Ultomiris in patients with severe .....»»

Shares of Alnylam Pharmaceuticals Inc. rallied 7.4% in premarket trading Monday, after Blackstone Group Inc. confirmed that it was investing.....»»

Inovio Pharmaceuticals Inc. plans to begin human testing of its coronavirus vaccine candidate Monday — making it among the first biopharmaceutical companies to accomplish that goal. The Plymouth Meeting company's stock was trading up more than 3% at $7.....»»

The stock market got slammed again Monday with a record-setting loss as coronavirus fears and a potential crude oil price war sent stocks plummeting nearly 8%, prompting the market to halt trading within four minutes of opening. The S&P 500 dropp.....»»

The stock market was hit hard again Monday morning as coronavirus fears and a potential crude oil price war sent stocks plummeting 7%, prompting the market to halt trading within four minutes of opening. Milwaukee-area stocks have been dropping stead.....»»

The stock market got slammed again Monday morning as coronavirus fears and a potential crude oil price war sent stocks plummeting 7%, prompting the market to halt trading within four minutes of opening. The S&P 500 dropped 7% by 9:34 a.m., triggeri.....»»

Xeris Pharmaceuticals Inc. shares rallied in the extended session Monday after the drug maker said its diabetes treatment showed positive results in a .....»»

Progenics Pharmaceuticals, Inc. said Monday a late-stage trial of a treatment for prostate cancer met.....»»

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) shares ended Monday's session nearly 15% higher after Canaccord Genuity said the stock's mid-September sell-off was unjustified.  Latest Ratings for ZYNE .....»»

Shares of Aslan Pharmaceuticals Ltd. soared 77% in active premarket trading Monday, after the Singapore-based biopharmaceutical company revealed po.....»»

Reata Pharmaceuticals Inc. shares were halted in the extended session Monday as the biotech drug developer reported positive results from a late-stage kidney disease treatment study. Reata shares were flat, following a .....»»

Reata Pharmaceuticals Inc. shares surged after hours Monday as the biotech company announced positive results from a .....»»

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Shares of Acadia Pharmaceuticals Inc. rocketed 87% toward a 4-year high in premarket trading Monday, after the biopharmaceutical company said a phase 3 trial of its treatment for dementia-related psychosis met its primary endpoint. Th.....»»